Brentwood, Tenn.-based Surgery Partners is doubling down on independence following the decision not to proceed with Bain Capital’s proposed acquisition, according to the company’s second quarter ...

Q2 2025 Earnings Call Transcript August 5, 2025 Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.3363, ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...

Explore Surgery Partners' Q2 2025 performance with $826M revenue & 9% EBITDA growth. Learn about M&A strategy, leadership changes, & market outlook.

UnitedHealth Group has announced the appointment of Wayne DeVeydt, former CEO of ASC chain Surgery Partners, as its new chief financial officer, effective September 2. Here are three points to know: 1 ...

United Health Group named Bain Capital executive Wayne DeVeydt its next chief financial officer, starting Sept. 2. DeVeydt will replace John Rex, CFO since 2016, who will become strategic advisor to ...

The healthcare mergers and acquisitions (M&A) market remained active in Q2 2025, with several sectors including physician practice management ...

Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 4.3% in the morning session after Bank of America ...

The Bain and Botanic joint venture is dubbed GenesisM. The platform is designed to meet the “clinical and commercial manufacturing needs” of life science tenants, the partners said in a July ...

Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries.

We came across a bullish thesis on Surgery Partners, Inc. on Valueinvestorsclub.com by Shoe. In this article, we will summarize the bulls’ thesis on SGRY. Surgery Partners, Inc.’s share was trading at ...